Alex Federation
Alex Federation is Co-Founder and CEO at Talus Bioscience. Alex was Lead Bioinformatics Scientist & Pharma Alliance Manager at SEngine Precision Medicine and Senior Data Scientist at Navigating Cancer. Alex was also Founder and Director at University of Rochester Summer Research Experience. Alex held a Research Fellow role at Altius Institute for Biomedical Sciences.
Alex Federation says AI drug-discovery models proliferate but lack lab validation, urges third‑party testing
Alex Federation attended an AI drug discovery conference and reports many new models lack experimental lab validation, with most evaluated on the same public datasets; he argues for more third‑party and in‑house lab testing and discusses challenges in choosing small‑molecule targets and success metrics.
Alex Federation: Ptarmigan-1 enables structure-free, hours-long compound screens versus $1M+ months-long co-folding runs for single targets
Alex Federation explains that traditional co-folding models for large-scale drug discovery are computationally intensive and costly (potentially over $1M per target), while Ptarmigan-1 performs structure-free screening to produce testable compounds within hours, enabling faster lab follow-up.
Organizations
See all 8-
Talus Bioscience Executive Officer, Director, Promoter 2024–present, Chief Executive Officer & Co-Founder 2020–present · current
-
SEngine Precision Medicine Lead Bioinformatics Scientist & Pharma Alliance Manager 2020 · past
-
Navigating Cancer Senior Data Scientist 2019–2020 · past
Education
-
Harvard University Ph.D., Chemical Biology · 2011–2015
-
University of Rochester B.S., Chemistry, Cell & Developmental Biology · 2007–2011